• No results found

Jak, Janus kinase

Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors

<p>Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK)&nbsp;Inhibitors</p>

... Head-to-head trial would be the best strategy to compare directly two treatments, but they are very dif fi cult and expensive to organize, due to the very large sample size needed. Therefore, in most cases, data come from ...

9

Type I interferonopathies in pediatric rheumatology

Type I interferonopathies in pediatric rheumatology

... 15; JAK: Janus kinase; JASL: Japanese autoinflammatory syndrome with lipodystrophy; JMP: joint contractures, muscle atrophy, microcytic anemia and panniculitis-induced lipodystrophy syndrome; MAVS: ...

12

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?

Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?

... 3; JAK: Janus Kinase; STAT: Signal Transducer and Activator of Transcription; MAPK: Mitogen Activated Protein Kinase; IFN: Interferon; HCV: Hepatitis C Virus; GWAS: Genome Wide Association ...

6

Characterization of Immunodeficiency in a Patient With Growth Hormone Insensitivity Secondary to a Novel STAT5b Gene Mutation

Characterization of Immunodeficiency in a Patient With Growth Hormone Insensitivity Secondary to a Novel STAT5b Gene Mutation

... hormone; JAK, Janus kinase; STAT, signal transducer and activator of transcription; GHR, growth hormone receptor; IL-2R, interleukin 2 receptor; Treg, regulatory T cell; NK, natural killer; SDS, SD ...

11

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop

... ICI: Immune checkpoint inhibitor; IFN: Interferon; IHC: Immunohistochemistry; IO: Immuno-oncology; JAK: Janus kinase; LOFU: Low-intensity focused ultrasound; MHC: Major histocompatibilit[r] ...

8

In silico docking analysis of Janus kinase enzymes and phytochemicals

In silico docking analysis of Janus kinase enzymes and phytochemicals

... three Janus kinases (JAK 1, JAK2 and JAK3) (Table ...inhibit JAK 1, 2 and 3 at a rate comparable to the positive control ligands indicated that this phenolic compound might act as a natural inhibitor ...

7

Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)

Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)

... The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is crucial to haem- atopoiesis and immune development, in addition to other essential ...the JAK/STAT ...

6

Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation

Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation

... substrate; JAK‑STAT : Janus kinase‑Signal Transducer and Activator of Transcription; JNK: c‑Jun N‑terminal kinase; K: clot kinetics; LDL: low‑density lipoprotein; LpL: lipoprotein lipase; LPS: ...

15

Sphingosine 1-Phosphate-Metabolizing Enzymes Control Influenza Virus Propagation and Viral Cytopathogenicity

Sphingosine 1-Phosphate-Metabolizing Enzymes Control Influenza Virus Propagation and Viral Cytopathogenicity

... of Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2) in type I IFN signaling (1, 8, 41), we performed inhibitor studies block- ing their kinase activities to further determine the involvement ...

8

Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren’s syndrome uncovered through gene expression meta analysis

Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren’s syndrome uncovered through gene expression meta analysis

... the Janus kinase/signal transducer and activator of tran- scription (JAK/STAT) signaling pathway and previously related to immune disorders ...[35]. JAK/STAT signaling promotes IFN-stimulated ...

8

Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma

Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma

... protein kinase; JAK – STAT: Janus Kinase/Signal Transducer and Activator of Transcription; JNK: cJun N-terminal kinase; LMP-1: Epstein-Barr Virus -encoded latent membrane protein-1; NF- ...

7

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia

... The IL7 receptor is a heterodimeric receptor consisting of the IL7 receptor alpha chain (IL7R) and the common gamma chain (IL2RG). These receptor units associate with Janus kinase 1 (JAK1) and JAK3, ...

5

Mitogen-Activated Protein Kinase Kinase 2, a Novel E2-Interacting Protein, Promotes the Growth of Classical Swine Fever Virus via Attenuation of the JAK-STAT Signaling Pathway

Mitogen-Activated Protein Kinase Kinase 2, a Novel E2-Interacting Protein, Promotes the Growth of Classical Swine Fever Virus via Attenuation of the JAK-STAT Signaling Pathway

... protein kinase kinase/extracellular regulated kinase (MEK1/2/ERK1/2) cascade is involved in the replica- tion of several members of the Flaviviridae family, including hepatitis C virus and dengue ...

14

Role of janus kinase inhibitors in the treatment of alopecia areata

Role of janus kinase inhibitors in the treatment of alopecia areata

... function, which in turn phosphorylates STAT component. Phosphorylation of the STAT component dimerizes and activates STATs. The activated STATs then will, in turn, translocate to the DNA in the nucleus and promote tran- ...

13

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor

... Other targets identified in the pacritinib kinome (Table 1) underlie other cancers and may prove important for their treatment. For non-JAK/FLT3 tyrosine kinases, ROS1 showed promising response to pacritinib and ...

9

Checkpoint inhibitors in hematological malignancies

Checkpoint inhibitors in hematological malignancies

... of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling ...the JAK/STAT signaling pathway, extra signaling for PD-L1 expression is ...

16

CP690,550 inhibits oncostatin M induced JAK/STAT signaling pathway in rheumatoid synoviocytes

CP690,550 inhibits oncostatin M induced JAK/STAT signaling pathway in rheumatoid synoviocytes

... the Janus kinase (JAK)/signal transducer and activator of tran- scription (STAT) cascade ...Recently, JAK inhibition has been shown to have a prominent effect on autoimmune dis- eases ...

10

Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

... of Janus kinase (JAK)2 (4), which then phosphor- ylates GHRs and the signal transducers and activators of transcrip- tion (STATs), including STAT1, -3, and -5 ...

7

α Lipoic Acid Inhibits Expression of IL 8 by Suppressing Activation of MAPK, Jak/Stat, and NF κB in H  pylori Infected Gastric Epithelial AGS Cells

α Lipoic Acid Inhibits Expression of IL 8 by Suppressing Activation of MAPK, Jak/Stat, and NF κB in H pylori Infected Gastric Epithelial AGS Cells

... (MAPK), janus kinase/signal transducers and activators of transcription (Jak/Stat), and oxidant-sensitive transcrip- tion factor, nuclear factor kappa-light-chain-enhancer of activated B cells ...

5

A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation

A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation

... fusion kinase encoded by the Philadelphia (Ph) chromosome, which arises from the chromosomal translocation t(9;22), is a major cause of chronic myeloid leukemia (CML) as well as of Ph + acute lymphoblastic ...

5

Show all 6700 documents...

Related subjects